Literature DB >> 8507907

Dysmyelinating and demyelinating conditions in infancy.

E H Kolodny1.   

Abstract

The myelin membrane is essential for rapid conduction of nerve impulses through the central nervous system. Failure of myelination--dysmyelination--may arise through several mechanisms. The synthesis of a particular myelin protein can be defective, as occurs for proteolipid protein in Pelizaeus-Merzbacher disease and for myelin basic protein in the 18q- syndrome. Delay in myelination with a more generalized diminution in white matter is characteristic of many inherited metabolic diseases, including galactosemia, pyridoxine-dependent seizure disorder, glutaric aciduria type 1, and infantile Refsum disease. Demyelination or breakdown in myelin is characteristic of metachromatic leukodystrophy, Krabbe disease, mitochondrial disorders, adrenoleukodystrophy, Canavan disease, Alexander disease, and orthochromatic leukodystrophy. A fourth category is reserved for malformation syndromes. These include Cockayne, Fukuyama, Walker-Warburg, and Angelman syndromes. Demyelination also occurs in HIV-infected individuals with central nervous system findings and in multiple sclerosis. Much of the evidence for leukodystrophy in these disorders comes from neuroimaging. Some of these disorders are treatable.

Entities:  

Mesh:

Year:  1993        PMID: 8507907

Source DB:  PubMed          Journal:  Curr Opin Neurol Neurosurg        ISSN: 0951-7383


  7 in total

Review 1.  Leukoencephalopathies and metabolic diseases.

Authors:  Antonio Giorgio; Nicola De Stefano
Journal:  Neurol Sci       Date:  2008-10       Impact factor: 3.307

Review 2.  Proton magnetic resonance spectroscopy in brain white matter disorders.

Authors:  N De Stefano; A Federico; D L Arnold
Journal:  Ital J Neurol Sci       Date:  1997-12

Review 3.  Diffusion-weighted MR imaging in leukodystrophies.

Authors:  Zoltan Patay
Journal:  Eur Radiol       Date:  2005-07-15       Impact factor: 5.315

4.  Expanded Phenotypic Definition Identifies Hundreds of Potential Causative Genes for Leukodystrophies and Leukoencephalopathies.

Authors:  Veronica M Urbik; Marilyn Schmiedel; Haille Soderholm; Joshua L Bonkowsky
Journal:  Child Neurol Open       Date:  2020-07-08

5.  An in vivo accelerated developmental myelination model for testing promyelinating therapeutics.

Authors:  Karen Lariosa-Willingham; Kimmo K Lehtimäki; Diana Miszczuk; Dmitri Leonoudakis; Timo Bragge; Laura Tolppanen; Antti Nurmi; Megan Flanagan; Janelle Gibson; David Wilson; Jennifer Stratton
Journal:  BMC Neurosci       Date:  2022-05-25       Impact factor: 3.264

6.  MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis.

Authors:  Daniela Prayer; Nicole Grois; Helmut Prosch; Helmut Gadner; Anthony J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

7.  Assessment of dysmyelination with RAFFn MRI: application to murine MPS I.

Authors:  David Satzer; Christina DiBartolomeo; Michael M Ritchie; Christine Storino; Timo Liimatainen; Hanne Hakkarainen; Djaudat Idiyatullin; Silvia Mangia; Shalom Michaeli; Ann M Parr; Walter C Low
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.